Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




New products

Related to GENE THERAPY FOR FATAL NEURODEGENERATIVE DISEASE IN CHILDREN

    • Company GigaCyte
    • Human Hippocampal Stem Cells
    • These human hippocampal stem cells have been launched for use in neuroscience and cytotoxicity testing. These cells have been extensively characterized for neural stem cell and mature neural markers. This human organ-derived product differentiates i
    • Company NextGen
    • CNS Biomarker Assay
    • The csfdiscovery43 cerebrospinal fluid (CSF) multiplex assay is for central nervous system (CNS) biomarker discovery and qualification. The assay simultaneously measures 43 human CSF proteins that are thought to have potential as biomarkers in CNS d
    • Company Sigma-Aldrich Corporation
    • Neurobiology Antibody Array
    • The Panorama® neurobiology antibody array is a proteomics tool to measure the relative level of protein expression in cell or tissue extracts. The array contains 224 human antibodies spotted in duplicate on a nitrocellulose-coated glass slide th
  • Page 1 of 1 (3items) 1 

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll